[The effect of 6-mercaptopurine riboside in 55 cases of childhood leukemia].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to J Akatsuka.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A 2-year-old boy with B-cell lymphoma (stage IV) in the first complete remission received myeloablative treatment followed by peripheral blood stem cell autotransplantation and is surviving event-free for 18 months. Reconstitution of all cell lines occurred very rapidly, ie, a level of 1000 leukocytes per microliter was reached after 9 days, that of 500 granulocytes per microliter after 10 days, and platelets were substituted only once. This result suggests that PBSCT can be safely employed during consolidation therapy for malignant disorders because of its short duration of bone marrow suppression.
Since January 1987, chemoprophylaxis and empiric therapy with antifungal drugs have been used routinely in neutropenic children with neoplasms. The incidence of terminal invasive fungal infection (IFI) diagnosed by autopsy findings is compared in two groups: group A, consisting of 25 patients autopsied between January 1982 and December 1986, and group B, consisting of 14 patients autopsied between January 1987 and December 1991. There was no difference in the incidence of IFI between the two groups, but the characteristics of IFI appeared to differ. With the recent intensification of chemotherapy, the patients in group B had more risk factors for IFI. It might therefore have been anticipated that group B patients may have shown an increase in IFI. No such increase was observed, suggesting that the prophylaxis was effective. Autopsy findings also showed that the target organs of IFI were localized and that systemic candidiasis was decreased in group B. It is thus concluded that the present antifungal countermeasures are effective, although some problems still remain.
We conducted a survey by questionnaire to clarify the actual conditions of neonates born to mothers with autoimmune thrombocytopenic purpura (ATP) in Japan. We investigated 93 pregnancies (1 resulting in twins) in 31 hospitals between 1985 and 1994. Forty-nine of the neonates (52%) had thrombocytopenia (below 150 x 10(9)/L). Nineteen neonates (20%) showed a bleeding tendency, but this was generally mild. In only one neonate (1%) (a case of asymptomatic intracranial hemorrhage, ICH), deep bleeding occurred due to thrombocytopenia. The lowest platelet count of neonates after birth occurred on day 4, not on day 0. There was no correlation between maternal and neonatal platelet counts. However, there was an apparent correlation between the neonatal platelet count on day 0 and the lowest platelet count after birth. Treatment of the mothers with intravenous high-dose gamma-globulin and prednisolone did not prevent risk of neonatal thrombocytopenia significantly.